Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

2.370

-0.100 (-4.05%)

At close: Oct 29, 2025, 4:00 PM EDT

2.400

+0.030 (1.27%)

After-hours: Oct 29, 2025, 7:44 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Allogeneic Chimeric Antigen Receptor - T Cell Therapies	9.99M	Log In	Log In	Log In	Log In	Upgrade
Allogeneic Chimeric Antigen Receptor - T Cell Therapies Growth	-71.01%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	9.27M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-71.71%	Log In	Log In	Log In	Log In	Upgrade
Rest of World	724.00K	Log In	Log In	Log In	Log In	Upgrade
Rest of World Growth	-57.59%	Log In	Log In	Log In	Log In	Upgrade